Study of the Biological Activities of Toxic Shock Syndrome Toxin-1

MICROBIOLOGY and IMMUNOLOGY

Volumn 30, Issue 5, 1986, Pages 469-483

  Fujikawa, Hiroshi ^b   Kamagata, Yusuke ^a   Wakai, Mariko ^a   Yoshioka, Morimasa ^a   Igarashi, Hideo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TOXIN;

ETIOLOGY; HUMAN; PATHOGENESIS; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANIMALS; BACTERIAL TOXINS; CELLS, CULTURED; CHROMATOGRAPHY, GEL; ENTEROTOXINS; FEMALE; INTERLEUKIN-2; KINETICS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MITOGENS; SUPERANTIGENS; T-LYMPHOCYTES;

ARACHIS HYPOGAEA; MURINAE; STAPHYLOCOCCUS AUREUS;

EID: 0022891173     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1986.tb02973.x     Document Type: Article

References (35)

1. Bergdoll, M.S., Crass, B.A., Reiser, R.F., Robbins, R.N., and Davis, J.P. 1981. A new staphylo-coccal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet i: 1017–1021.
2. Bonnard, G.D., Yasaka, K., and Jacobson, D. 1979. Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cells. J. Immunol. 123: 2704–2708.
3. Bonventre, P.F., Weckbach, L., Staneck, J., Sclievert, P.M., and Thompson, M. 1983. Produc-tion of staphylococcal enterotoxin F and pyrogenic enterotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect. Immun. 40: 1023–1029.
4. Calvano, S.E., Quimby, F.W., Antonacci, A.C., Reiser, F.R., Bergdoll, M.S., and Dineen, P. 1984. Analysis of the mitogenic effect of toxic shock toxin on human peripheral blood mono-nuclear cells in vitro. Clin. Immunol. Immunopathol. 33: 99–110.
5. Clark, B.R., Mills, B.J., Horikoshi, K., Shively, J.E., and Todd, C.W. 1984. Production of mitogen-free immune interferon and T cell growth factor by human peripheral blood lympho-cytes induced with biotin-labeled staphylococcal enterotoxin A. J. Immunol. Methods 67: 371–377.
6. Davis, J.P., Chesney, P.J., Wand, P.J., Laventure, M., and the Investigation and Laboratory Team. 1980. Toxic-shock syndrome. Epidemiologic features, recurrence, risk factors, and pre-vention. N. Engl. J. Med. 303: 1429–1435.
7. Farrar, J.J., Fuller-Farrar, J., Simon, P.L., Hilfiker, M.L., Stadler, B.M., and Farrar, W.L. 1980. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125: 2555—2558.
8. Farrar, J.J., Mizel, S.B., Fuller-Farrar, J., Farrar, W.L., and Hilfiker, M.L. 1980. Macrophage-independent activation of helper T cells. I. Production of interleukin 2. J. Immunol. 125: 793–798.
9. Gillis, S., Ferm, M.M., Ou, W., and Smith, K.A. 1978. T cell growth factor: Parameters of production and quantitative microassay for activity. J. Immunol, 120: 2027–2032.
10. Gillis, S., and Smith, K.A. 1977. Long term culture of tumor-specific cytotoxic T cells. Nature 268: 154–156.
11. Gilman, S.C., Rosenberg, J.S., and Feldman, J.D. 1983. Inhibition of interleukin synthesis and T cell proliferation by a monoclonal anti-Ia antibody. J. Immunol. 130: 1236–1240.
12. Hamuro, J. 1984. Interleukins. Kodansha Scientific Ltd., Tokyo.
13. Haregewoin, A., Godal, T., Mustafa, A.S., Belehu, A., and Yemaneberham, T. 1983. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature 303: 342–344.
14. Harel-Bellan, A., Joskowics, M., Fradelizi, D., and Eisen, H. 1983. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. U.S.A. 80: 3466–3469.
15. Hoffmann, M.K., Koenig, S., Mittler, R.S., Oettgen, H.F., Ralph, P., Galanos, C., and Ham-merling, U. 1979. Macrophage factor controlling differentiation of B cells. J. Immunol. 122: 497–502.
16. Igarashi, H., Fujikawa, H., Usami, H., Kawabata, S., and Morita, T. 1984. Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome toxins. Infect. Immun. 44: 175–181.
17. Ikejima, T., Dinarello, C.A., Gill, D.M., and Wolff, S.M. 1984. Induction of human interleukin 1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J. Clin. Invest. 73: 1312–1320.
18. Julius, M.H., Simpson, E., and Herzenberg, L.A. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645–649.
19. Larkin, S.M., Williams, D.N., Osterholm, M.T., Tofte, R.W., and Posalaky, Z. 1982. Toxic shock syndrome: Clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 96 (part 2): 858–864.
20. Oppenheim, J. J., and Gery, I. 1982. Interleukin 1 is more than an interleukin. Immunol. Today 3: 113–119.
21. Paetkau, V., Bleackley, R.C., Riendeau, D., Harnish, D.G., and Holowachuk, E.W. 1985. Toward the molecular biology of IL 2. Contemp. Top. Mol. Immunol. 10: 35–61.
22. Paris, A.L., Herwaldt, L.A., Blume, D., Schmid, G.P., Shands, K.N., and Broome, C.V. 1982. Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann. Intern. Med. 96 (part 2): 852–857.
23. Poindexter, N.J., and Schlievert, P.M. 1985. Toxic-shock syndrome toxin 1-induced proliferation of lymphocytes: Comparison of the mitogenic response of human, murine, and rabbit lympho-cytes. J. Infect. Dis. 151: 65–72.
24. Rasheed, J.K., Arko, R.J., Feeley, J.C., Chandler, F.W., Thornsberry, C., Gibson, R.J., Cohen, M.L., Jeffries, C.D., and Broome, C.V. 1985. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect. Immun. 47: 598–604.
25. Reiser, R.E., Robbins, R.N., Khoe, G.P., and Bergdoll, M.S. 1983. Purification and some physicochemical properties of toxic-shock toxin. Biochemistry 22: 3907–3912.
26. Reisner, Y., Linker-Israeli, M., and Sharon, N. 1976. Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin. Cell. Immunol. 25: 129–134.
27. Schlievert, P.M. 1983. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: Possible role in toxic-shock syndrome. J. Infect. Dis. 147: 391–398.
28. Schlievert, P.M., Shands, K.N., Dan, B.B., Schmid, G.P., and Nishimura, R.D. 1981. Identi-fication and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143: 509–516.
29. Shands, K.N., Schmid, G.P., Dan, B.B., Blum. D., Guidotti, R.J., Hargrett, N.T., Anderson, R.L., Hill, D.L., Broome, C.V., Band, J.D., and Fraser, D.W. 1980. Toxic-shock syndrome in menstruating women. Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303: 1436–1442.
30. Smith, K.A., and Ruscetti, F.W. 1981. T cell growth factor and the culture of cloned functional T cells. Adv. Immunol. 131: 137–175.
31. Steeg, P.S., Moore, R.N., Johnson, H.M., and Oppenheim, J.J. 1982. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J. Exp. Med. 156: 1780–1793.
32. Todd, J., Fishaut, M., Kapral, F., and Welch, T. 1978. Toxic-shock syndrome associated with phage-group-1 staphylococci. Lancet ii: 1116–1118.
33. Tofte, R.W., and Williams, D.N. 1982. Clinical and laboratory manifestation of toxic shock syndrome. Ann. Intern. Med. 96 (part 2): 843–847.
34. Uchiyama, T., Kamagata, U., and Yoshioka, M. 1984. Mechanism of lipopolysaccharide-induced immunosuppression: Immunological activity of B cell subsets responding to T-depen-dent or T-independent antigens in lipopolysaccharide-preinjected mice. Infect. Immunol. 45: 367–371.
35. Watson, J., Gillis, S., Marbrook, J., Mochizuki, D., and Smith, K.A. 1979. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphocytes. J. Exp. Med. 150: 849–861.